Home West China Hospital's Patented Ginger-Infused Protein Powder Drives 5.8kg Weight Loss and 6.2% Body Fat Reduction in Clinical Trial

West China Hospital's Patented Ginger-Infused Protein Powder Drives 5.8kg Weight Loss and 6.2% Body Fat Reduction in Clinical Trial

May 21, 2026 08:00 CST Updated 08:00

Losing Muscle Mass Rapidly During Fat Loss, Hitting a Metabolic Plateau When Gaining Muscle—Stuck at a Bottleneck No Matter How You Train. What Should You Do?Top-tier (Grade A Tertiary) hospitals have long provided the standard answer.


Recently, West China Hospital of Sichuan University released a public notice on the conversion of scientific and technological achievements, stating that the hospital intends to“A Composite Protein Powder of Small Yellow Ginger and Its Preparation Method and Application”Transferred to Chengdu Huashou Health Technology Co., Ltd. via an exclusive license. The patent is jointly held by the First People's Hospital of Yunnan Province and West China Hospital of Sichuan University, with a transfer amount ofRMB 200,000 + 10% commission on sales revenue. The inventors of this patent areWu Bian and his team


image (93).png

Image from the official website of West China Hospital, Sichuan University


What substantive benefits does it offer me? How soon can I start using it?


Hitting a fat-loss plateau, struggling to maintain wellness routines, and ineffective products, these clinical pain points have long plagued individuals during their body management phase.


As the Director of the Department of Gastrointestinal and Weight Loss Surgery at the First People's Hospital of Yunnan Province,Dr. Wu BianHaving cultivated the field of scientific weight loss for many years and consistently disseminated evidence-based weight management knowledge through personal media platforms, we have now joined forces with West China Hospital to collaboratively develop this patented formulation of small yellow ginger composite protein.


The core functionality of this patent is“Weight Loss + Muscle Gain + Metabolism Boost” All-in-One Solution. Clinical data from 12 weeks have validated that subjects with a BMI ≥30 experienced an average weight loss of 5.8 kg and a 6.2% reduction in body fat percentage, while gaining 1.6 kg of muscle mass and increasing basal metabolic rate by 7.5%, with no significant adverse reactions observed throughout the study.


As for when it will be available?The patent has already been commercialized through an exclusive license. Mass production is expected to follow, with the hope that it will soon be incorporated into products such as protein powders, meal replacements, and functional beverages.


On what basis can it be translated? Can it address unmet clinical needs?


To translate scientific achievements into practical applications, one cannot rely solely on concepts; tangible advantages are essential.The confidence in commercializing this patent stems from three key breakthroughs:


Resolved Raw Material Pain Points:By employing microwave-assisted ultrasonic extraction combined with microencapsulation, this approach not only enhances the dissolution rates of gingerols and shogaols but also masks the pungency of small yellow ginger, thereby addressing the longstanding issues of low active ingredient content, poor absorption, and difficulty in long-term consumption.


Backed by clinical data:The results of the 12-week randomized, double-blind, controlled trial directly demonstrate its efficacy in weight loss and muscle gain, as well as its safety—evidence that many influencer-endorsed products fail to provide.


Fills the Intervention Gap in Metabolism and Muscle Building:Traditional functional foods mostly focus on single-nutrient supplementation, whereas this product simultaneously addresses metabolic regulation and muscle maintenance, precisely filling the clinical gap in demand for “weight management + sarcopenia intervention.”


Moreover, compared with similar technologies, its manufacturing process can improve raw material utilization, and it is expected to reduce costs during future mass production, making it more affordable for a broader population.


Does it truly have “financial prospects”? What is its translational value?


From a commercial perspective, this patent holds significant potential:


First, China elevated weight management to a national strategy in 2019 and officially launched the “Year of Weight Management” in 2024., with joint promotion by 16 government departments, weight reduction has become a clear policy priority. This technology, licensed exclusively for RMB 200,000 plus a 10% royalty on sales revenue, has already achieved technology transfer at two hospitals, thereby establishing a clear path to monetization.


Secondly, the track is wide enough:Functional weight management and sports nutrition are currently hot sectors. This patent can be extended to various product forms, including protein powder, meal-replacement porridge, energy drinks, nutritional bars, and functional biscuits, covering multiple scenarios such as fitness enthusiasts, individuals with obesity, those in a sub-health state, and interventions for sarcopenia in the middle-aged and elderly population, thereby reaching a broad audience.


Finally, it has capitalized on the industry’s upgrade trend:Functional foods are evolving from “basic supplementation” to “health intervention,” with hospital endorsement, clinical data, and compliant formulations constituting the scarcest core competencies for such products, thereby creating significant barriers to entry and clear competitive advantages for subsequent commercialization.


Overall, it is not a concept product hyped up by marketing, but rather one that addresses the fat-loss pain points of ordinary people, solves industry challenges through scientific breakthroughs, and provides investors with a clear path to commercialization.